The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism

Among the myriad of molecules produced by the liver, both bile acids and their precursors, the oxysterols are becoming pivotal bioactive lipids which have been underestimated for a long time. Their actions are ranging from regulation of energy homeostasis (i.e., glucose and lipid metabolism) to infl...

Full description

Bibliographic Details
Main Authors: Charlotte Lefort, Patrice D. Cani
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/2/400
id doaj-bac2946c73904a41a001391060a79e9b
record_format Article
spelling doaj-bac2946c73904a41a001391060a79e9b2021-02-17T00:00:29ZengMDPI AGCells2073-44092021-02-011040040010.3390/cells10020400The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling MetabolismCharlotte Lefort0Patrice D. Cani1Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Walloon Excellence in Life sciences and BIOtechnology (WELBIO), UCLouvain, Université Catholique de Louvain, Av. E. Mounier, 73 B1.73.11, 1200 Brussels, BelgiumMetabolism and Nutrition Research Group, Louvain Drug Research Institute, Walloon Excellence in Life sciences and BIOtechnology (WELBIO), UCLouvain, Université Catholique de Louvain, Av. E. Mounier, 73 B1.73.11, 1200 Brussels, BelgiumAmong the myriad of molecules produced by the liver, both bile acids and their precursors, the oxysterols are becoming pivotal bioactive lipids which have been underestimated for a long time. Their actions are ranging from regulation of energy homeostasis (i.e., glucose and lipid metabolism) to inflammation and immunity, thereby opening the avenue to new treatments to tackle metabolic disorders associated with obesity (e.g., type 2 diabetes and hepatic steatosis) and inflammatory diseases. Here, we review the biosynthesis of these endocrine factors including their interconnection with the gut microbiota and their impact on host homeostasis as well as their attractive potential for the development of therapeutic strategies for metabolic disorders.https://www.mdpi.com/2073-4409/10/2/400liverbile acidsoxysterolsinflammationgut microbiotasteatosis
collection DOAJ
language English
format Article
sources DOAJ
author Charlotte Lefort
Patrice D. Cani
spellingShingle Charlotte Lefort
Patrice D. Cani
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Cells
liver
bile acids
oxysterols
inflammation
gut microbiota
steatosis
author_facet Charlotte Lefort
Patrice D. Cani
author_sort Charlotte Lefort
title The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
title_short The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
title_full The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
title_fullStr The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
title_full_unstemmed The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
title_sort liver under the spotlight: bile acids and oxysterols as pivotal actors controlling metabolism
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2021-02-01
description Among the myriad of molecules produced by the liver, both bile acids and their precursors, the oxysterols are becoming pivotal bioactive lipids which have been underestimated for a long time. Their actions are ranging from regulation of energy homeostasis (i.e., glucose and lipid metabolism) to inflammation and immunity, thereby opening the avenue to new treatments to tackle metabolic disorders associated with obesity (e.g., type 2 diabetes and hepatic steatosis) and inflammatory diseases. Here, we review the biosynthesis of these endocrine factors including their interconnection with the gut microbiota and their impact on host homeostasis as well as their attractive potential for the development of therapeutic strategies for metabolic disorders.
topic liver
bile acids
oxysterols
inflammation
gut microbiota
steatosis
url https://www.mdpi.com/2073-4409/10/2/400
work_keys_str_mv AT charlottelefort theliverunderthespotlightbileacidsandoxysterolsaspivotalactorscontrollingmetabolism
AT patricedcani theliverunderthespotlightbileacidsandoxysterolsaspivotalactorscontrollingmetabolism
AT charlottelefort liverunderthespotlightbileacidsandoxysterolsaspivotalactorscontrollingmetabolism
AT patricedcani liverunderthespotlightbileacidsandoxysterolsaspivotalactorscontrollingmetabolism
_version_ 1724265938552881152